author-photo

Diehl Ja

University of Pennsylvania

18

Papers

1213

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Tumor progression and the different faces of the PERK kinase

2016 Oncogene
Show All
- Source
- Cite
- Save
Citations (37)
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.

2016 PLOS Genetics
Show All
- Source
- Cite
- Save
Citations (27)
PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers

2015 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (91)
ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis

2014 Oncogene
Show All
- Source
- Cite
- Save
Citations (17)
The ζ Isoform of Diacylglycerol Kinase Plays a Predominant Role in Regulatory T Cell Development and TCR-Mediated Ras Signaling

2013 Science Signaling
Show All
- Source
- Cite
- Save
Citations (50)
Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses

2013 Oncogene
Show All
- Source
- Cite
- Save
Citations (50)
Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma

2012 American Journal of Cancer Research
Show All
- Source
- Cite
- Save
Citations (27)
PERK Utilizes Intrinsic Lipid Kinase Activity To Generate Phosphatidic Acid, Mediate Akt Activation, and Promote Adipocyte Differentiation

2012 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (84)
Abstract SY06-02: Activation of the UPR by c-Myc promotes transformation and tumorigenesis via cytoprotective autophagy

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation

2011 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (40)